Translucence Biosystems, Inc.
Irvine, CA Translucence Biosystems, Inc.
- UEI
- VMEAMDALXAS1
- CAGE
- 84RE9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 5270 California Ave #300, Irvine, CA 92617, USA
- Website
- translucencebio.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Brain-wide quantification of blood-brain barrier penetrating antibody therapeutics - the process of delivering… | National Institute on Aging | $3,733,679 | |
| Clearbot: a system for fully automated, high-throughput tissue clearing and immunostaining - summary tissue clearing… | National Institute of Mental Health | $919,310 | |
| Brain-wide quantitative mapping of microglia activation | National Institute of Mental Health | $449,956 | |
| Rapid evaluation of neuronal activity in the intact whole brain at single cell resolution - project summary here we seek… | National Institute of Mental Health | $6,727,791 | |
| Rapid evaluation of neuronal activity in the intact whole-brain at single cell resolution | National Institute of Mental Health | $224,979 |
About Translucence Biosystems, Inc.
Translucence Biosystems, Inc. is a corporate, for-profit organization headquartered in Irvine, California, specializing in advanced neuroscience technology and imaging solutions. Registered in the System for Award Management (SAM) since June 2018, the company develops sophisticated neurological research tools that leverage artificial intelligence, machine learning, and advanced imaging techniques. As a manufacturer of scientific research goods, Translucence Biosystems focuses on creating innovative platforms and technologies that enable more precise and comprehensive brain research methodologies.
The company has been awarded federal grants primarily from the National Institute of Mental Health (NIMH), focusing on developing advanced neurological research technologies. Their recent federal grant awards include a $375,000 project grant for developing a "Vasculature Subtraction Parenchymal Quantification (VSPQ)" workflow, which aims to enhance 3D brain imaging and analysis capabilities for measuring antibody therapeutic drug penetration in the brain. Another significant project, ClearBot, involves creating an automated system for tissue clearing and immunostaining, designed to streamline brain sample processing. Translucence Biosystems has also engaged in sub-grant work, including a research and development sub-award with Kitware Inc. in September 2021. These projects demonstrate the company's commitment to advancing neurological research technologies through innovative software, imaging platforms, and automated research tools, with a strong emphasis on artificial intelligence and high-resolution analysis techniques.
Quick answers
What is Translucence Biosystems, Inc.'s UEI?
Translucence Biosystems, Inc.'s Unique Entity ID (UEI) in SAM.gov is VMEAMDALXAS1.
What is Translucence Biosystems, Inc.'s CAGE code?
Translucence Biosystems, Inc.'s CAGE code is 84RE9.
What is Translucence Biosystems, Inc.'s primary NAICS code?
Translucence Biosystems, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Translucence Biosystems, Inc. located?
Translucence Biosystems, Inc.'s physical address in SAM.gov is 5270 California Ave #300, Irvine, CA 92617, USA.
Is Translucence Biosystems, Inc. registered in SAM.gov?
Yes. Translucence Biosystems, Inc.'s SAM.gov registration is active through August 7, 2027.
What is Translucence Biosystems, Inc.'s most recent federal award?
Translucence Biosystems, Inc.'s most recent federal grant award is Brain-wide quantification of blood-brain barrier penetrating antibody therapeutics - the process of delivering… (R44AG090130), from National Institute on Aging, on September 20, 2025.
On GovTribe
See Translucence Biosystems, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors